# Revivant

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/revivant

- Industry: Medical Devices & Equipment
- Headquarters: Sunnyvale, US
- Website: www.revivant.com
- Latest round: Series B (Aug 1, 2003)
- Investors on record: 5

## About

Revivant is a technology company focused on improving consumer experiences through innovative solutions, offering a platform that enhances operational efficiencies and customer engagement across various sectors.Revivant operates primarily in the technology sector, providing solutions to optimize business processes. Founded in Sunnyvale, US, the company was acquired by Zoll Medical in August 2003 for USD 7.00 mn. The founder's details are not explicitly provided, but the acquisition indicates potential strategic pivots in their business operations.Revivant.com specializes in offering innovative solutions aimed at enhancing consumer experiences through advanced technology. The company’s core product is a sophisticated platform designed to streamline operational processes and improve customer engagement across various sectors. This platform addresses critical use cases, such as optimizing supply chain management, managing customer relationships, and enhancing data analytics capabilities. Revivant serves a diverse client base, including retail businesses, e-commerce platforms, and service-oriented companies, primarily within North America and Europe. With the launch of its flagship offerings in the last few years, the company has positioned itself as a key player in the competitive landscape of digital transformation solutions.Revivant.com generates revenue through a combination of subscription models and direct partnerships with its clients. Businesses subscribe to the platform on a tiered pricing basis, which allows them to access various features depending on their needs. This structure facilitates transactions directly between Revivant and its clientele, including B2B engagements where companies utilize the platform for their operational requirements. Alongside subscription revenues, strategic partnerships with larger corporations enhance the company's market reach and visibility. While specific pricing plans may vary, the revenue model is grounded in providing scalable solutions that cater to the evolving demands of its customer base.Revivant plans to leverage its recent acquisition to enhance its product offerings and expand its market presence. The company is focusing on developing new features for its platform, with a target release in the upcoming quarters. Geographic expansion is also on the horizon, aiming to penetrate additional markets in Europe and Asia by 2025. The funding from the acquisition is expected to support these initiatives, enabling Revivant to develop and market new products effectively.

## Funding rounds

- Series B, Aug 1, 2003 — Adams Street Partners, CHL Medical Partners, MedVenture Associates, Canaan Partners, Three Arch Partners

## Investors

- Adams Street Partners (https://capitalatlas.ai/funds/adams-street-partners) — Series B
- CHL Medical Partners (https://capitalatlas.ai/funds/chl-medical-partners) — Series B
- MedVenture Associates (https://capitalatlas.ai/funds/medventure-associates) — Series B
- Canaan Partners (https://capitalatlas.ai/funds/canaan-partners) — Series B
- Three Arch Partners (https://capitalatlas.ai/funds/three-arch-partners) — Series B